Navigation Links
Implicit Licenses Clinical Stage Antibody Program From Lilly
Date:2/24/2009

esent opportunity for third party non-dilutive funding. Implicit is currently developing oglufanide disodium for the treatment of serious infections including those caused by a variety of biothreat agents (under a contract with the US Defense Threat Reduction Agency).

This news release contains forward-looking statements. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a difference include, among others, the completion of clinical trials, the FDA review processes and other governmental regulation, Implicit's ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, the ability to effectively market products, and other factors described in Implicit's filings with the Australian Securities and Investment Commission. Implicit does not undertake any duty to update forward looking statements.


'/>"/>
SOURCE Implicit Bioscience Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Implicit Awarded US $16.3 Million U.S. Government Contract to Develop Immunomodulatory Drug for Biodefense Threats
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
4. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
5. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
6. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
7. Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications
8. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
9. Syngenta Licenses Chromatin Gene Stacking Technology
10. Utrecht University Licenses MetaDrug From GeneGo for Drug Innovation
11. Prometheus Licenses COLAL-PRED(R) From Alizyme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... The global market for molecular diagnostics is ... to a new study by Grand View Research, Inc. ... subsequent introduction of advanced cancer diagnostic technologies are expected ... next six years. Moreover, the growing global base of ... with disease triggering lifestyle habits such as smoking and ...
(Date:7/31/2014)... 31, 2014 SoundConnect , ... company, is proud to announce the addition of ... Adobe Connect’s elearning tools to quickly deploy and ... with training tools for desktop and mobile learning ... is the perfect online training solution, enabling organizations ...
(Date:7/30/2014)... Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... the quarter ended June 30, 2014 on Wednesday, August ... Regulus will host a conference call and ... Eastern Daylight Time to discuss its second quarter 2014 ...
(Date:7/30/2014)... FRANCISCO , July 30, 2014 ... Congress evaluated the safety and efficacy of CSL ... rejection following kidney transplants in highly sensitized patients. ... inhibitor of the complement system. The ... in significant increases in the levels of complement ...
Breaking Biology Technology:Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 2Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 3Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 5SoundConnect Enhances Portfolio with Adobe Connect Learning Management System (LMS) 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3
... to IT Nirvana, and I like it. , ,OK, maybe thats ... the VP of IT at Rayovac , it sounds like ... fighting for respect. They get invited to the table when its ... They arent nearly deaf from the constant ringing of alarm bells. ...
... Rayovac signs $1.2 billion deal for United Industries , ... Rayovac Corp. has negotiated a contract to purchase St. ... and common stock, with the deal expected to close in ... the lawn and garden product market, obtaining United brands such ...
... of digital convergence on Thursday at the Consumer Electronics Show ... service. , ,Designed as part of the companys plan ... digital video recording and Internet service in a set-top box. ... connection. , ,In his keynote address, SBC chairman Edward Whitacre ...
Cached Biology Technology:Is Rayovac IT Nirvana? An exclusive interview with Rick Dempsey, VP of IT 2Is Rayovac IT Nirvana? An exclusive interview with Rick Dempsey, VP of IT 3Is Rayovac IT Nirvana? An exclusive interview with Rick Dempsey, VP of IT 4Tech Digest: Rayovac, Inacom, TomoTherapy, Regal-Beloit, Modine 2SBC blends TV, video, music and the Internet in a new media box 2
(Date:7/31/2014)... German . ... to a sponge that soaks up liquids. Hence, these ... greenhouse gases. However, loading of many MOFs is inhibited ... now report in Nature Communications that the ... This can be prevented by water-free synthesis and storing ...
(Date:7/31/2014)... has been made to help better identify and treat those ... narrowing and enlarging of medium sized arteries in the body, ... organs causing damage. In a new report appearing in August ... scientists provide evidence that that FMD may not be limited ... a connection to abnormalities of bones and joints, as well ...
(Date:7/31/2014)... A Florida State University researcher found that bacteria in ... components of the oil released during the Deepwater Horizon ... the most toxic contaminants. , In two new studies ... Mason found a species of bacteria called Colwellia ... ethylbenzene and xylene compounds that were released as part ...
Breaking Biology News(10 mins):Free pores for molecule transport 2Scientists discover biochemical mechanisms contributing to fibromuscular dysplasia 2
... class of drugs used by millions worldwide to effectively ... impact in Multiple Sclerosis (MS) patients treated with high ... the Montreal Neurological Institute (MNI), McGill University, demonstrates that ... in the central nervous system. The findings, published in ...
... a young person who dies suddenly should always be ... identify if they too are at risk of sudden ... European Society of Human Genetics today (Tuesday 26 May). ... fellow at the Department of Cardiogenetics, Academic Medical Centre, ...
... have been able to identify genetic factors that influence the ... Ms Lisette Stolk, a researcher from Erasmus MC, Rotterdam, ... of Human Genetics today ( Monday 25 May) that a ... eventually help to improve the clinical treatment of infertile women. ...
Cached Biology News:One size does not fit all 2Comprehensive cardiogenetic testing for families of sudden unexplained death victims can save lives 2Identification of genetic variants affecting age at menopause could help improve fertility treatment 2
... Osmometer for both 0.2 and 2.0 mL samples for freezing point determinations. ... Bar code reading capability with optional scanner. RS-232 port. Microprocessor-controlled autocalibration. ... ... ...
MAb to Hu-IFN-Gamma RC2 (CD118), NON-Neutralizing, Clone MMHGR-2 Binds to but does not neutralize human interferon gamma receptor...
Recombinant Rat CINC-2 alpha, CF...
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice...
Biology Products: